A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/12 (2006.01) A61K 38/19 (2006.01) A61K 48/00 (2006.01) A61K 49/00 (2006.01) A61L 27/22 (2006.01) C07K 14/52 (2006.01) C07K 16/28 (2006.01) C12N 15/11 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2679545
Osteopontin for the prediction and treatment of cardiovascular diseases The present invention relates to the use of endothelial progenitor cells (EPCs) and osteopontin for the treatment of cardiovascular diseases or complications. The invention also relates to the use of EPC osteopontin levels as a marker of the risk of the development of these cardiovascular complications. In particular, the invention provides compositions and methods based on osteopontin and the genes encoding osteopontin.
La présente invention concerne l'utilisation de cellules progéniteurs endothéliales (EPC) et d'ostéopontine pour le traitement de maladies ou de complications cardiovasculaires. L'invention concerne également l'utilisation des taux d'ostéopontine des EPC comme un marqueur du risque de développement de ces complications cardiovasculaires. En particulier, l'invention procure des compositions et des procédés basés sur l'ostéopontine et les gènes codant pour l'ostéopontine.
Barry Frank
Duffy Angela
Liew Yie Loong Aaron
O'brien Timothy
Samali Afshin
National University Of Ireland Galway
Parlee Mclaws Llp
LandOfFree
Osteopontin for the prediction and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteopontin for the prediction and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteopontin for the prediction and treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1485334